These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 319937)

  • 21. Efficacy of metolazone and furosemide in children with furosemide-resistant edema.
    Arnold WC
    Pediatrics; 1984 Nov; 74(5):872-5. PubMed ID: 6493882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal of the suppressed potassium excretion during treatment with combinations of antikaliuretic drugs (spironolactone, canrenone, triamterene, amiloride) in patients with liver cirrhosis.
    Radó JP; Sawinsky I; Juhos E
    Int J Clin Pharmacol Biopharm; 1976 Oct; 14(3):163-7. PubMed ID: 1002353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination diuretic treatment in severe heart failure: a randomised controlled trial.
    Channer KS; McLean KA; Lawson-Matthew P; Richardson M
    Br Heart J; 1994 Feb; 71(2):146-50. PubMed ID: 8130022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of low-dose captopril in addition to furosemide and spironolactone in patients with decompensated liver disease during blunted diuresis.
    van Vliet AA; Hackeng WH; Donker AJ; Meuwissen SG
    J Hepatol; 1992 May; 15(1-2):40-7. PubMed ID: 1324274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of metolazone addition on furosemide resistant cases of edema.
    Kshirsagar NA; Gupta KC; Paul T; Shah BP; Vora KK; Sanghvi B; Acharya VN; Mehta JM; Sheth UK
    J Assoc Physicians India; 1978 Oct; 26(10):915-23. PubMed ID: 750570
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy and safety of metolazone in renal failure and the nephrotic syndrome.
    Bennett WM; Porter GA
    J Clin Pharmacol; 1973; 13(8):357-64. PubMed ID: 4579972
    [No Abstract]   [Full Text] [Related]  

  • 27. METABOLIC STUDIES WITH THE DIURETIC TRIAMTERENE IN PATIENTS WITH CIRRHOSIS AND ASCITES.
    GINSBERG DJ; SAAD A; GABUZDA GJ
    N Engl J Med; 1964 Dec; 271():1229-35. PubMed ID: 14234267
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level.
    Arroyo V; Bosch J; Casamitjana R; Cabrera J; Rivera F; Rodés J
    Gut; 1980 Oct; 21(10):855-9. PubMed ID: 7439805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of a new diuretic agent (metolazone) in patients with edema and ascites.
    Lowenthal DT; Shear L
    Arch Intern Med; 1973 Jul; 132(1):38-41. PubMed ID: 4716425
    [No Abstract]   [Full Text] [Related]  

  • 30. Metolazone and its role in edema management.
    Sica DA
    Congest Heart Fail; 2003; 9(2):100-5. PubMed ID: 12671341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of diuretic measures in hydropic conditions. II. Results in liver cirrhosis].
    Dürr F; Kaufmann W; Horbach L; Michaelis J; Neuhaus GA; Praetorius F
    Klin Wochenschr; 1969 Nov; 47(21):1142-51. PubMed ID: 5382003
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of aldactone on potassium storage in patients with ascitic cirrhosis].
    Lévy VG; Lassale B; Del Corso A; Caroli J
    Ann Med Interne (Paris); 1970 Feb; 121(2):183-90. PubMed ID: 5491199
    [No Abstract]   [Full Text] [Related]  

  • 33. Spironolactone diuresis in patients with cirrhosis and ascites.
    Eggert RC
    Br Med J; 1970 Nov; 4(5732):401-3. PubMed ID: 5481518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperkalemic changes during spironolactone therapy for cirrhosis and ascites, with special reference to hyperkalemic intermittent paralysis.
    Radó JP; Marosi J; Szende L; Takó J
    J Am Geriatr Soc; 1968 Aug; 16(8):874-86. PubMed ID: 5666934
    [No Abstract]   [Full Text] [Related]  

  • 35. Relative potency of prorenoate potassium and spironolactone in attenuating diuretic induced hypokalaemia.
    McInnes GT; Harrison IR; Shelton JR; Perkins RM; Clarke JM
    Br J Clin Pharmacol; 1984 Aug; 18(2):169-74. PubMed ID: 6487456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Captopril/metolazone induced renal failure.
    Hogg KJ; Hillis WS
    Lancet; 1986 Mar; 1(8479):501-2. PubMed ID: 2869237
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of cirrhotic edemas with triamterene, amiloride and spirolactone. New clinical and biological facts].
    Vesin P
    Schweiz Med Wochenschr; 1971 Mar; 101(11):398-401. PubMed ID: 5558553
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system.
    Lenaerts A; Codden T; Meunier JC; Henry JP; Ligny G
    Hepatology; 2006 Oct; 44(4):844-9. PubMed ID: 17006921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of premenstrual tension with metolazone: a double-blind evaluation of a new diuretic.
    Werch A; Kane RE
    Curr Ther Res Clin Exp; 1976 Jun; 19(6):565-72. PubMed ID: 819215
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical evaluation of metolazone, a long-acting antihypertensive/diuretic.
    Weingarten C
    Curr Ther Res Clin Exp; 1976 Dec; 20(6):737-44. PubMed ID: 827419
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.